Cardiovascular System

• 

  Subject Areas on Research

  • 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. 
  • A historical perspective on the discovery of adenyl purines. 
  • Acute kidney injury and cardiovascular outcomes in acute severe hypertension. 
  • Adam10 is essential for early embryonic cardiovascular development. 
  • Adverse events after discontinuing medications in elderly outpatients. 
  • Adverse reactions to protamine. 
  • American Society of Echocardiography Cardiovascular Technology and Research Summit: a roadmap for 2020. 
  • An updated overview on Wnt signaling pathways: a prelude for more. 
  • Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholamines. 
  • Anaphylactic and anaphylactoid reactions. A review. 
  • Anger control and cardiovascular outcomes. 
  • Angiotensin converting enzyme inhibitors and the cardiovascular system. 
  • Angiotensin-converting enzyme inhibition: research advances and clinical implications. 
  • Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence. 
  • BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. 
  • Baroreflex-mediated cardiovascular responses to hyperbaric oxygen. 
  • Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. 
  • Biomarkers for the Prevention of Heart Failure: Are We There Yet? 
  • Biomechanics: cell research and applications for the next decade. 
  • Caffeine affects cardiovascular responses to stress. 
  • Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. 
  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum. 
  • Cardiovascular effects of mental arithmetic in Type A and Type B females. 
  • Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system. 
  • Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women. 
  • Cardiovascular nuclear imaging: balancing proven clinical value and potential radiation risk. 
  • Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. 
  • Cardiovascular regulation in response to multiple hemorrhages: analysis and parameter estimation. 
  • Cardiovascular responses during upright and semi-recumbent cycle ergometry testing. 
  • Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. 
  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. 
  • Childhood to Early-Midlife Systolic Blood Pressure Trajectories: Early-Life Predictors, Effect Modifiers, and Adult Cardiovascular Outcomes. 
  • Chromosomal distribution of the human cardiovascular transcriptome. 
  • Circulating versus local renin-angiotensin system in cardiovascular homeostasis. 
  • Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. 
  • Combination regimens with statin, niacin, and intestinally active LDL-lowering drugs: alternatives to high-dose statin therapy? 
  • Connection, a microcomputer program for storing and analyzing structural properties of neural circuits. 
  • Consent for organ donation after circulatory death at U.S. transplant centers. 
  • Consequences of space radiation on the brain and cardiovascular system. 
  • Cross-talk Between Nitrate-Nitrite-NO and NO Synthase Pathways in Control of Vascular NO Homeostasis. 
  • Defining a Mobile Health Roadmap for Cardiovascular Health and Disease. 
  • Definition and management of anemia in patients infected with hepatitis C virus. 
  • Demand-flow airway pressure release ventilation as a partial ventilatory support mode: comparison with synchronized intermittent mandatory ventilation and pressure support ventilation. 
  • Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. 
  • Discrimination, dispositions, and cardiovascular responses to stress. 
  • Disrupting nicotine reinforcement: from cigarette to brain. 
  • Effect-directed analysis of Elizabeth River porewater: developmental toxicity in zebrafish (Danio rerio). 
  • Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. 
  • Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. 
  • Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets. 
  • Effects of exercise and weight loss on mental stress-induced cardiovascular responses in individuals with high blood pressure. 
  • Effects of pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet. 
  • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. 
  • Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. 
  • Emulating Leonardo da Vinci (1452-1519): the convergence of science and art in biomedical research and practice. 
  • Evaluation of beta-adrenergic influences on cardiovascular and metabolic adjustments to physical and psychological stress. 
  • Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction? 
  • Exposure to concentrated coarse air pollution particles causes mild cardiopulmonary effects in healthy young adults. 
  • From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). 
  • Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder. 
  • Genetic cardiovascular risk prediction: are we already there? 
  • Genomics of Cardiovascular Measures of Autonomic Tone. 
  • Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. 
  • Hostility is related to blunted beta-adrenergic receptor responsiveness among middle-aged women. 
  • How well does early-career investigators' cardiovascular outcomes research training align with funded outcomes research? 
  • Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. 
  • Implications of local angiotensin production in cardiovascular physiology and pharmacology. 
  • Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. 
  • In Response. 
  • Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. 
  • Increased scan pitch for vascular and thoracic spiral CT. 
  • Influence of an antagonist of slow-reacting substance of anaphylaxis on the cardiovascular manifestations of hypoxia in piglets. 
  • Influence of lung volume on the interaction between cardiac output and cerebrovascular regulation during extreme apnoea. 
  • Inhibitory action of a new sympathomimetic amino (DU-21220) on the nongravid uterus. 
  • Interactions of respiratory and cardiovascular adjustments to behavioral stressors. 
  • Is there a causal relationship between the amount of alcohol consumption and stroke risk? 
  • L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake. 
  • Late gadolinium cardiovascular magnetic resonance in the assessment of myocardial viability. 
  • Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study). 
  • Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. 
  • Low educational attainment, John Henryism, and cardiovascular reactivity to and recovery from personally relevant stress. 
  • Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. 
  • Magnetic resonance imaging of blood flow with a phase subtraction technique. In vitro and in vivo validation. 
  • Magnetic resonance microscopy of chick embryos in ovo. 
  • Making Every Mobile Heart Count! 
  • Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine. 
  • Mechanisms of functional loss in patients with chronic lung disease. 
  • Mechanosensitive channels in striated muscle and the cardiovascular system: not quite a stretch anymore. 
  • Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. 
  • Molecular biology in cardiology: recent developments and opportunities for clinical applications. 
  • NIEHS/EPA Workshops. Cellular migration. 
  • New developments in cardiovascular adrenergic receptor pharmacology: molecular mechanisms and clinical relevance. 
  • Nonadditive effects of PAHs on Early Vertebrate Development: mechanisms and implications for risk assessment. 
  • Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. 
  • Perceived racism and cardiovascular reactivity and recovery to personally relevant stress. 
  • Perceived stress and biological risk: is the link stronger in Russians than in Taiwanese and Americans? 
  • Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. 
  • Position as a variable for cardiovascular responses during exercise. 
  • Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients. 
  • Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus. 
  • Random Plasma Glucose Levels and Cardiovascular Risk. 
  • Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function. 
  • Relation of cardiovascular responses to mental stress and cardiac vagal activity in coronary artery disease. 
  • Reply: Pulse Pressure and Cardiovascular Death. 
  • Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry". 
  • Review of methods used to study oxygen transport at the microcirculatory level. 
  • Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship. 
  • S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. 
  • Safety of bevacizumab in patients with metastatic breast cancer. 
  • Sex differences in respiratory and circulatory cost during hypoxic walking: potential impact on oxygen saturation. 
  • Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. 
  • Structural characterization of the neural circuit responsible for control of cardiovascular functions in higher vertebrates. 
  • Synergistic effects of exposure to concentrated ambient fine pollution particles and nitrogen dioxide in humans. 
  • Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. 
  • The Working Group report on Science-Based Categories for Abstracts: Submitted to the annual scientific sessions. American Heart Association. 
  • The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. 
  • The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety. 
  • The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. 
  • The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. 
  • The role of the central nervous system in septic shock. I. Pathologic changes following intraventricular and intracisternal endotoxin in the dog. 
  • The volume problem in hypoperfusion states and appropriate therapy. 
  • Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart. 
  • Trafficking of G protein-coupled receptors. 
  • Training cardiovascular outcomes researchers: A survey of mentees and mentors to identify critical training gaps and needs. 
  • Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. 
  • Type A behavior, family history of hypertension, and cardiovascular responsivity among black women. 
  • Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. 
  • Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation. 
  • Vascular medicine and surgery in ancient Egypt. 
  • Vasodilator administration in the presence of beta-adrenergic blockade. 
  • Ventilatory effects of angiotensin and vasopressin in conscious rats. 
  • Waking up to the importance of sleeping well for cardiovascular health. 
  • What Is Needed Now to Improve Cardiovascular Clinical Registries in the Future. 
  • When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often. 
• 

  Keywords of People

  • Herndon II, James Emmett, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Hogan, Brigid L. M., George Barth Geller Distinguished Professor for Research in Molecular Biology, Cell Biology
  • Johnson, G. Allan, Charles E. Putman University Distinguished Professor of Radiology, Biomedical Engineering
  • McDonnell, Donald Patrick, Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, in the School of Medicine, Pharmacology & Cancer Biology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Rubin, Geoffrey D, George Barth Geller Distinguished Professorship for Research in Cardiovascular Diseases, Radiology
  • Starmer, Charles Franklin, Professor Emeritus of Computer Science, Computer Science